Literature DB >> 16451358

High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins.

Roberto Perricone1, Gioia Di Muzio, Carlo Perricone, Roberto Giacomelli, Domenico De Nardo, Luigi Fontana, Caterina De Carolis.   

Abstract

PROBLEM: To determine the levels of peripheral blood natural killer (NK) cells in healthy women and recurrent aborters, and the effect of intravenous immunoglobulins (IVIGs) on these levels. METHOD OF STUDY: A total of 659 women were evaluated for NK cells by means of flow cytofluorimetry: 42 non-pregnant healthy women, 394 non-pregnant recurrent spontaneous abortion (RSA) women, 36 pregnant healthy women and 187 pregnant RSA women. Fifty-four of the pregnant RSA women were treated with IVIG; in 18 of them NK cells were measured immediately before and after the very first IVIG infusion (0.5 g/kg body weight).
RESULTS: Blood NK cell results were increased in RSA pregnant/non-pregnant women, and significantly reduced by IVIG, even after the very first infusion. In RSA pregnant women treated by means of IVIG therapy, 92.3% success rate was observed.
CONCLUSIONS: High levels of NK cells are detected in women affected by RSA. IVIGs are capable of decreasing them with a short- and long-term efficacy, allowing having a very high success rate of pregnancies in RSA women.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16451358     DOI: 10.1111/j.1600-0897.2005.00356.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  13 in total

1.  Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure.

Authors:  P Triggianese; C Perricone; P Conigliaro; M S Chimenti; R Perricone; C De Carolis
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-10       Impact factor: 3.219

2.  Advances of intravenous immunoglobulin G in modulation of anti-fetal immunity in selected at-risk populations: science and therapeutics.

Authors:  O B Christiansen
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 3.  NK cell abnormality and its treatment in women with reproductive failures such as recurrent pregnancy loss, implantation failures, preeclampsia, and pelvic endometriosis.

Authors:  Atsushi Fukui; Mai Kamoi; Ayano Funamizu; Kohei Fuchinoue; Hitomi Chiba; Megumi Yokota; Rie Fukuhara; Hideki Mizunuma
Journal:  Reprod Med Biol       Date:  2015-04-11

4.  7th International Immunoglobulin Conference: Immunomodulation.

Authors:  M G Danieli; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

5.  Outcomes of Empirical Treatment With Intravenous Immunoglobulin G Combined With Low-Dose Aspirin in Women With Unexplained Recurrent Pregnancy Loss.

Authors:  Ju Hee Kim; Sung Hoon Kim; Nuri Yang; Yuri Ko; Sa Ra Lee; Hee Dong Chae
Journal:  J Korean Med Sci       Date:  2022-06-27       Impact factor: 5.354

Review 6.  NK cells, autoantibodies, and immunologic infertility: a complex interplay.

Authors:  Caterina De Carolis; Carlo Perricone; Roberto Perricone
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

7.  Elevated natural killer cell levels and autoimmunity synergistically decrease uterine blood flow during early pregnancy.

Authors:  Hyun Jeong Yi; Jung Hyun Kim; Hwa Seon Koo; Ju Youn Bae; Sun Wha Cha; Kwang Moon Yang
Journal:  Obstet Gynecol Sci       Date:  2014-05-15

8.  A high dose intravenous immunoglobulin therapy for women with four or more recurrent spontaneous abortions.

Authors:  Hideto Yamada; Masamitsu Takeda; Yoko Maezawa; Yasuhiko Ebina; Ryoichi Hazama; Kenji Tanimura; Yukio Wakui; Shigeki Shimada
Journal:  ISRN Obstet Gynecol       Date:  2012-09-11

9.  Consecutive successful pregnancies subsequent to intravenous immunoglobulin therapy in a patient with recurrent spontaneous miscarriage.

Authors:  Michael F Diejomaoh; Zainab Bello; Waleed Al Jassar; Jiri Jirous; Kavitha Karunakaran; Asiya T Mohammed
Journal:  Int Med Case Rep J       Date:  2015-12-11

10.  High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.

Authors:  Sarah M McAlpine; Sarah E Roberts; John J Heath; Fabian Käsermann; Andrew C Issekutz; Thomas B Issekutz; Beata Derfalvi
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.